133 related articles for article (PubMed ID: 11289280)
1. Correlating computed tomography and positron emission tomography scan with operative findings in metastatic colorectal cancer.
Johnson K; Bakhsh A; Young D; Martin TE; Arnold M
Dis Colon Rectum; 2001 Mar; 44(3):354-7. PubMed ID: 11289280
[TBL] [Abstract][Full Text] [Related]
2. Intra-abdominal recurrence of colorectal cancer detected by radioimmunoguided surgery (RIGS system).
Sardi A; Workman M; Mojzisik C; Hinkle G; Nieroda C; Martin EW
Arch Surg; 1989 Jan; 124(1):55-9. PubMed ID: 2910248
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum.
Whiteford MH; Whiteford HM; Yee LF; Ogunbiyi OA; Dehdashti F; Siegel BA; Birnbaum EH; Fleshman JW; Kodner IJ; Read TE
Dis Colon Rectum; 2000 Jun; 43(6):759-67; discussion 767-70. PubMed ID: 10859074
[TBL] [Abstract][Full Text] [Related]
4. Impact of 18F-FDG PET/CT on therapeutic decisions in patients with colorectal cancer and liver metastases.
Georgakopoulos A; Pianou N; Kelekis N; Chatziioannou S
Clin Imaging; 2013; 37(3):536-41. PubMed ID: 23116727
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver.
Vitola JV; Delbeke D; Sandler MP; Campbell MG; Powers TA; Wright JK; Chapman WC; Pinson CW
Am J Surg; 1996 Jan; 171(1):21-6. PubMed ID: 8554144
[TBL] [Abstract][Full Text] [Related]
6. Fluorodeoxyglucose whole-body positron emission tomography in colorectal cancer patients studied in routine daily practice.
Ruhlmann J; Schomburg A; Bender H; Oehr P; Robertz-Vaupel GM; Vaupel H; Wolter H; Kozak B; Biersack HJ
Dis Colon Rectum; 1997 Oct; 40(10):1195-204. PubMed ID: 9336115
[TBL] [Abstract][Full Text] [Related]
7. Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors.
Böhm B; Voth M; Geoghegan J; Hellfritzsch H; Petrovich A; Scheele J; Gottschild D
J Cancer Res Clin Oncol; 2004 May; 130(5):266-72. PubMed ID: 14767761
[TBL] [Abstract][Full Text] [Related]
8. Is (18)F-fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making?
Staib L; Schirrmeister H; Reske SN; Beger HG
Am J Surg; 2000 Jul; 180(1):1-5. PubMed ID: 11036130
[TBL] [Abstract][Full Text] [Related]
9. Multimodality imaging of melanoma metastases to the abdomen and pelvis.
Benaissa A; Fornès P; Ladam-Marcus V; Grange F; Amzallag-Bellenger E; Hoeffel C
Clin Imaging; 2011; 35(6):452-8. PubMed ID: 22040790
[TBL] [Abstract][Full Text] [Related]
10. Imaging prior to second-look surgery for carcinoma.
Bennett WF; Bova JG
Semin Surg Oncol; 1991; 7(3):138-42. PubMed ID: 2068446
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence.
Deleau C; Buecher B; Rousseau C; Kraeber-Bodéré F; Flamant M; des Varannes SB; Frampas E; Galmiche JP; Matysiak-Budnik T
Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):275-81. PubMed ID: 21304319
[TBL] [Abstract][Full Text] [Related]
12. Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancer.
Flamen P; Stroobants S; Van Cutsem E; Dupont P; Bormans G; De Vadder N; Penninckx F; Van Hoe L; Mortelmans L
J Clin Oncol; 1999 Mar; 17(3):894-901. PubMed ID: 10071281
[TBL] [Abstract][Full Text] [Related]
13. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?
Selzner M; Hany TF; Wildbrett P; McCormack L; Kadry Z; Clavien PA
Ann Surg; 2004 Dec; 240(6):1027-34; discussion 1035-6. PubMed ID: 15570208
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic laparoscopy and laparoscopic ultrasonography optimize the staging and resectability of intraabdominal neoplasms.
Tsioulias GJ; Wood TF; Chung MH; Morton DL; Bilchik A
Surg Endosc; 2001 Sep; 15(9):1016-9. PubMed ID: 11443448
[TBL] [Abstract][Full Text] [Related]
15. Protocol considerations for positron emission tomography-computed tomography of the abdomen and pelvis.
Almusa O; Daly B; Shreve P
Semin Ultrasound CT MR; 2008 Aug; 29(4):251-62. PubMed ID: 18795492
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography/computed tomographic scans compared to computed tomographic scans for detecting colorectal liver metastases: a systematic review.
Patel S; McCall M; Ohinmaa A; Bigam D; Dryden DM
Ann Surg; 2011 Apr; 253(4):666-71. PubMed ID: 21475005
[TBL] [Abstract][Full Text] [Related]
17. Patterns of neoplastic spread in colorectal cancer: implications for surveillance CT studies.
Giess CS; Schwartz LH; Bach AM; Gollub MJ; Panicek DM
AJR Am J Roentgenol; 1998 Apr; 170(4):987-91. PubMed ID: 9530048
[TBL] [Abstract][Full Text] [Related]
18. Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography predicts extrahepatic metastatic potential of colorectal metastasis: a practical guide for yttrium-90 microsphere liver-directed therapy.
Wong CY; Gates VL; Tang B; Campbell J; Qing F; Lewandowski RJ; Thie J; Ho CL; Savin M; Salem R
Cancer Biother Radiopharm; 2010 Apr; 25(2):233-6. PubMed ID: 20423237
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation.
Rappeport ED; Loft A; Berthelsen AK; von der Recke P; Larsen PN; Mogensen AM; Wettergren A; Rasmussen A; Hillingsoe J; Kirkegaard P; Thomsen C
Acta Radiol; 2007 May; 48(4):369-78. PubMed ID: 17453514
[TBL] [Abstract][Full Text] [Related]
20. Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis.
Evangelista L; Cimitan M; Zattoni F; Guttilla A; Zattoni F; Saladini G
Scand J Urol; 2015; 49(5):345-53. PubMed ID: 25649494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
